Results 181 to 190 of about 98,698 (295)

Identification of an R1-type pyocin previously misannotated as a prophage in <i>Pseudomonas aeruginosa</i> ATCC 27853. [PDF]

Microbiology (Reading)
Pais RG, Müsken M, Loh B.
europepmc   +1 more source

Limbal vessel amputation combined with mitomycin for treatment of corneal neovascularization

, 2012
Xue Shang-ca
openalex   +1 more source

Case Report: Peritoneal disease from adrenal cortical carcinoma with hepatic metastases managed with cytoreductive surgery and multiple HIPEC sessions, resulting in survival beyond 13 years. [PDF]

Front Surg
Camarasa Perez A, Wijayawardana R, Ahmadi N, Morris DL.   +3 more
europepmc   +1 more source

Follow-up study on gastric cancer treated with mitomycin C prior to surgical operation.

, 1966
Noboru Sakakibara, Kunio Okajima, Shuzo OKUMURA   +2 more
openalex   +2 more sources

Effect of Benzalkonium, Mitomycin-C and Dexamethasone on Stress in Trabecular Meshwork Cells [PDF]

, 2015
Byung Moon Kim, Jae Woo Kim
openalex   +1 more source

Mitomycin-C for HPV-Positive and HPV-Negative Platinum-Refractory, Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Phase 2 Trial. [PDF]

Cancers (Basel)
Oppelt P, Ley J, Auberle C, Knapp B, Zaretsky J, Wan F, Adkins D.   +6 more
europepmc   +1 more source

Risk factors for choroidal detachment after trabeculectomy with mitomycin C

, 2013
Masaru Inatani, Haga, Shobayashi, Kojima, Toshihiro Inoue, Tanihara   +5 more
openalex   +2 more sources

Bioactive derivatives of the antimicrobial peptide esculentin-1a promote human dermal fibroblast migration and activate genes involved in early wound healing. [PDF]

BBA Adv
Cappiello F, Grisard E, Traversa A, Ranieri D, Mangoni ML.   +4 more
europepmc   +1 more source

Preoperative intravesical mitomycin C to reduce bladder recurrence in upper tract urothelial carcinoma - Insights from the landmark REBACARE trial. [PDF]

Indian J Urol
Jain MP.
europepmc   +1 more source

Fancl-mutant mice reveal central role of monoubiquitination in Fanconi anemia and a model for therapeutic gene editing. [PDF]

Blood Adv
Liu L, Glaser A, Isiaku AI, Fairfax K, Casolari DA, Ristovski A, Murphy V, van Twest S, Henrikus SS, Heraud-Farlow J, Granger E, Novakovic S, Monks O'Byrne SF, Tsui V, Conyers R, Gonda TJ, Crismani W, D'Andrea RJ, Heierhorst J, Deans AJ.   +19 more
europepmc   +1 more source